logo
Book a meeting
Celavie Biosciences

Celavie Biosciences

Biotechnology, Oxnard, California, United States, 1-10 Employees

celavie.com

  • facebook
  • LinkedIn

phone no Phone Number: 80********

Who is CELAVIE BIOSCIENCES

Celavie Biosciences is a privately-held company whose mission is to improve lives and restore hope by advancing regenerative stem cell therapies for the treatment of Parkinsons disease an...

Read More

lock icon Get Full Access
map
  • Oxnard, California, United States Headquarters: Oxnard, California, United States
  • 2006 Date Founded: 2006
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5621

checked-icon Does something look wrong? Fix it. | View contact records from CELAVIE BIOSCIENCES

Celavie Biosciences Org Chart and Mapping

Employees
Oleg Kopyov

Oleg Kopyov

CRO

Alex Kopyov

Alex Kopyov

Senior Researcher/Laboratory Manager

See Full Org Chart arrow
email-formate-icon
View Email Formats for Celavie Biosciences
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Celavie Biosciences

Answer: Celavie Biosciences's headquarters are located at Oxnard, California, United States

Answer: Celavie Biosciences's phone number is 80********

Answer: Celavie Biosciences's official website is https://celavie.com

Answer: Celavie Biosciences's revenue is $1 Million to $5 Million

Answer: Celavie Biosciences's SIC: 5621

Answer: Celavie Biosciences has 1-10 employees

Answer: Celavie Biosciences is in Biotechnology

Answer: Celavie Biosciences contact info: Phone number: 80******** Website: https://celavie.com

Answer: Celavie Biosciences is a privately-held company whose mission is to improve lives and restore hope by advancing regenerative stem cell therapies for the treatment of Parkinsons disease and other disorders of the central nervous system (CNS). The company develops undifferentiated, unmodified allogeneic pluripotent stem cell-based therapies, holds a strong IP portfolio, including 18 issued patents, and has an experienced management team blending expertise in concept and cell technology, product scalability and entrepreneurship. Celavet, a subsidiary, applies the same proprietary technologies for the treatment and prevention of serious veterinary diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access